Bronchiolitis obliterans syndrome (BOS) is thought to represent chronic allograft rejection. Primary graft dysfunction (PGD), acute cellular rejection (AR), lymphocytic bronchiolitis (LB), abnormal gastroesophageal reflux (GER) with microaspiration, and allograft infection have all been implicated as ...
Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT. Bone Marrow Transplant 2013;48:703-7.Holm AM, Riise GC, Hansson L, Brinch L, Bjortuft O, Iversen M, et al. Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT. Bone Marrow Transplant 2013;48:703-7...
Adding montelukast may be a promising treatment option in patients with low neutrophilic (<15%) BOS after lung transplantation, already or concurrently being treated with azithromycin. 展开 关键词: bronchiolitis obliterans syndrome chronic rejection lung transplantation montelukast ...
Montelukast for bronchiolitis obliterans syndrome after lung transplantation. Chest 2012;141(1):275-6. J Todd,S Palmer - 《Chest》 被引量: 0发表: 2012年 Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Bronchiolitis Obliterans syndrome-(BOS) is...
Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Bronchiolitis obliterans syndrome (BOS) is a form of chronic lung allograft dysfunction that affects a majority of lung transplant recipients and is the pr... JL Todd,SM Palmer - 《Chest》 被引量: 232发表: 2011年 Par...
Chronic GVHD (cGVHD) associated bronchiolitis obliterans syndrome (BOS) is a serious complication after allo-SCT, and lung transplantation (LTx) may be the ultimate treatment option. To evaluate this treatment, data on all patients with LTx after allo-SCT ever performed in Sweden, Norway, Denmark...
The clinical correlate of physiologic airflow obstruction is now known as bronchiolitis obliterans syndrome (BOS). Although the pathogenesis of OB is largely unknown, it is postulated that an insult to the small airway epithelium, such as aspiration or viral infection, induces an inflammatory ...
Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 749–759. Article Google Scholar Sakaida E, Nakaseko ...
Obliterative bronchiolitis poses a primary obstacle for long-term survival of lung transplant recipients and manifests clinically as bronchiolitis obliterans syndrome (BOS). Establishing a molecular level screening method to detect BOS-related proteome changes before its diagnosis by forced expiratory volume...
Given the internationally recognized definition of bronchiolitis obliterans syndrome (BOS) and longer follow up of heart-lung transplant recipients, it is possible to establish some of the major risk factors for development and progression of BOS. Between April 1984 and 31 December 1993, 157 patients...